N/A
Completed N=20
Smartphone Technology to Alleviate Malignant Pain (STAMP)
Cancer · Pain Management · Opioid Use Disorder
Source: ClinicalTrials.gov NCT03717402 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcomePrimary: Frequency of Patient Log Ins — 14 log ins to the application per patient
Summary
The purpose of the study is to develop the STAMP app (Smartphone Technology to Alleviate Malignant Pain). This app will be used by patients with advanced cancer to track symptoms and receive tailored symptom management advice.
This is a single arm pilot feasibility study of the application among patients with advanced cancer and chronic pain who are using opioids in the home setting. Patients will be asked to use the application for a four week period. Clinicians responsible for the patients' pain management will be asked to review alerts from the STAMP system and respond accordingly. The primary outcomes of the study relate to feasibility and acceptability.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Frequency of Patient Log Ins |
14 | — |
| PRIMARY Frequency of Symptom Survey Completion |
8 | — |
| SECONDARY E-scale Acceptability |
24 | — |
| SECONDARY Usability |
78.3 | — |
Eligibility Criteria
Inclusion Criteria
Patient Inclusion Criteria:
- Patient is cared for within participating clinic (PC)
- Age ≥21
- Diagnosed with locally advanced, metastatic solid tumor, or multiple myeloma being managed with palliative intent
- Chronic pain related to cancer or cancer treatment, persisting or at least two weeks
- Average pain rating of ≥4/10 currently, or at least one day within the past week
- Active prescription for short and/or long acting opioids
- Takes at least 1 opioid medication on most days
- Own a compatible smartphone:
- iPhone, have updated or willing to update it to the past 3 iOS version releases
- Android flagship devices with more than 5% market share, last 2 android version releases
Clinician Inclusion Criteria:
- Physicians and mid-level providers practicing in participating clinics and caring for a patient on the study
- Nurse Navigators working within participating clinics
Exclusion Criteria
Patient Exclusion Criteria:
- Cognitive impairment that would interfere with study participation, as judged by treating clinician
- Inability to speak English
- History of opioid use disorders
- Enrolled in hospice
- Currently hospitalized
- Use of opioids not supported by STAMP
- Pain primarily related to a recent surgery
- Currently has or has had recurrent bowel obstructions
- The following special populations are excluded: adults unable to consent, prisoners, and pregnant women.
Clinician Exclusion Criteria:
- Unwilling to participate
Data sourced from ClinicalTrials.gov (NCT03717402). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.